Author

P. Muti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Sacconi· 3 shared C. Pulito· 3 shared G. Blandino· 3 shared S. Strano· 3 shared R. Pellini· 2 shared S. Donzelli· 2 shared A. C. Palcau· 1 shared A. Gianni· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Sacconi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CircPVT1 sponges miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer

A. C. Palcau, C. Pulito, V. De Pascale, L. Casadei, M. C. Valerio, A. Sacconi, D. Rutigliano, S. Donzelli, R. F. Auciello, F. Pimpinelli, P. Muti, C. Botti, S. Strano, G. Blandino

This study identifies circPVT1 as a regulator of metabolic pathways in breast cancer by sponging miR-33a-5p, leading to increased c-MYC and GLS1 activity and promoting tumorigenesis.

bioRxiv · Jun 4, 2024 · PreprintCancer Biology

Molecular profiling in HNSCC patients targets potential responsiveness to ICIs

A. Sacconi, P. Muti, C. Pulito, R. Pellini, S. Strano, P. Bossi, G. Blandino

The paper identifies immune gene signatures associated with response to immunotherapy in HNSCC patients, validated through TCGA and clinical cohorts.

bioRxiv · Dec 16, 2022 · PreprintCancer Biology

TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.

A. Sacconi, S. Donzelli, C. Pulito, S. Ferrero, A. Morrone, M. Rigoni, F. Pimipinelli, F. Ensoli, G. Sanguineti, R. Pellini, N. Agrawal, E. Izumchenko, G. Ciliberto, A. Gianni, P. Muti, , G. Blandino

This study finds that TMPRSS2 expression is reduced in head and neck cancer tissues compared to normal tissues and is associated with poorer prognosis.

bioRxiv · Jun 16, 2020Cancer Biology